Mark D Mamlouk1,2, Bree Zimmerman3, Erin F Mathes4, Kristina W Rosbe5. 1. Department of Radiology, The Permanente Medical Group, Kaiser Permanente Medical Center Santa Clara, 700 Lawrence Expy, Santa Clara, CA, 95051, USA. mark.d.mamlouk@kp.org. 2. Department of Radiology and Biomedical Imaging, University of California, San Francisco, 505 Parnassus Ave, L371, San Francisco, CA, 94143, USA. mark.d.mamlouk@kp.org. 3. Department of Dermatology, University of California, San Francisco, Benioff Children's Hospital Oakland, 744 52nd St, Oakland, CA, 94609, USA. 4. Departments of Dermatology and Pediatrics, University of California, San Francisco, 1701 Divisadero Street, 3rd floor, San Francisco, CA, 94115, USA. 5. Department of Otolaryngology Head and Neck Surgery, Division of Pediatric Otolaryngology, University of California, San Francisco, 550 16th St, San Francisco, CA, 94158, USA.
Abstract
PURPOSE: To characterize the types of hearing loss, auditory-related imaging findings, and hemangioma characteristics in patients with Posterior fossa malformations, Hemangiomas, Arterial anomalies, Cardiac defects, and abnormalities of the Eye (PHACE) syndrome. METHODS: Retrospective medical records, audiologic data, and imaging review of all patients presenting to a tertiary care children's hospital with a proven diagnosis of PHACE syndrome from 2005 to 2016. RESULTS: Twelve patients were identified with hearing and imaging data. 5/12 had hearing loss, 1 had unilateral severe sensorineural loss with minor conductive component, 1 had unilateral moderate sensorineural loss with minor conductive component, 1 had mild bilateral conductive loss, 1 had bilateral hearing loss (left severe mixed and right severe sensorineural), and 1 had moderate bilateral conductive loss. All patients passed their newborn hearing screening. Of the 5 patients with hearing loss, 3 had IAC hemangiomas (1 bilateral), 3 had enlarged IACs with prominent posterior petrous bones (1 bilateral), 2 had dysgenesis of the cerebellar vermis and hemispheres, there was 1 patient each with a deformed pinna and middle ear and mastoid effusions, and 1 patient had no abnormal auditory-related imaging findings. Patients with hearing loss were more likely to have more areas of cutaneous hemangioma involvement (mean 6.4 vs 3.1, p = .05). Laterality of hearing impairment correlated with the side of cutaneous hemangioma in all patients with hearing loss. Treatment with systemic propranolol did not improve hearing. CONCLUSIONS: Patients with PHACE are at risk for hearing loss and may demonstrate radiologic abnormalities within the ear structures, although the type of hearing loss, imaging findings, and their respective correlation vary. While our results are limited by our small sample size, comprehensive audiology evaluations (as opposed to newborn screening testing only) should be considered for PHACE patients who have extensive cutaneous hemangioma or auditory-related imaging abnormalities, such as internal auditory canal hemangiomas.
PURPOSE: To characterize the types of hearing loss, auditory-related imaging findings, and hemangioma characteristics in patients with Posterior fossa malformations, Hemangiomas, Arterial anomalies, Cardiac defects, and abnormalities of the Eye (PHACE) syndrome. METHODS: Retrospective medical records, audiologic data, and imaging review of all patients presenting to a tertiary care children's hospital with a proven diagnosis of PHACE syndrome from 2005 to 2016. RESULTS: Twelve patients were identified with hearing and imaging data. 5/12 had hearing loss, 1 had unilateral severe sensorineural loss with minor conductive component, 1 had unilateral moderate sensorineural loss with minor conductive component, 1 had mild bilateral conductive loss, 1 had bilateral hearing loss (left severe mixed and right severe sensorineural), and 1 had moderate bilateral conductive loss. All patients passed their newborn hearing screening. Of the 5 patients with hearing loss, 3 had IAC hemangiomas (1 bilateral), 3 had enlarged IACs with prominent posterior petrous bones (1 bilateral), 2 had dysgenesis of the cerebellar vermis and hemispheres, there was 1 patient each with a deformed pinna and middle ear and mastoid effusions, and 1 patient had no abnormal auditory-related imaging findings. Patients with hearing loss were more likely to have more areas of cutaneous hemangioma involvement (mean 6.4 vs 3.1, p = .05). Laterality of hearing impairment correlated with the side of cutaneous hemangioma in all patients with hearing loss. Treatment with systemic propranolol did not improve hearing. CONCLUSIONS:Patients with PHACE are at risk for hearing loss and may demonstrate radiologic abnormalities within the ear structures, although the type of hearing loss, imaging findings, and their respective correlation vary. While our results are limited by our small sample size, comprehensive audiology evaluations (as opposed to newborn screening testing only) should be considered for PHACE patients who have extensive cutaneous hemangioma or auditory-related imaging abnormalities, such as internal auditory canal hemangiomas.
Authors: Anna M Chilosi; Alessandro Comparini; Maria F Scusa; Stefano Berrettini; Francesca Forli; Roberta Battini; Paola Cipriani; Giovanni Cioni Journal: Dev Med Child Neurol Date: 2010-03-19 Impact factor: 5.449
Authors: John N Bangiyev; Richard Gurgel; Sheryll L Vanderhooft; J Fredrik Grimmer Journal: Int J Pediatr Otorhinolaryngol Date: 2017-10-05 Impact factor: 1.675
Authors: Kelly J Duffy; Christina Runge-Samuelson; Michelle L Bayer; David Friedland; Cecille Sulman; Robert Chun; Joseph E Kerschner; Denise Metry; Denise Adams; Beth A Drolet Journal: Arch Dermatol Date: 2010-08-16
Authors: Emily F Rudnick; Eunice Y Chen; Scott C Manning; Jonathan A Perkins Journal: Int J Pediatr Otorhinolaryngol Date: 2008-12-09 Impact factor: 1.675
Authors: Sonam Dilwali; Lukas D Landegger; Vitor Y R Soares; Daniel G Deschler; Konstantina M Stankovic Journal: Sci Rep Date: 2015-12-22 Impact factor: 4.379